Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5046415 | 0.90 | PTGER2 (0.44) | PTGER2LTA4H | |
| SCHEMBL5049502 | 0.85 | PTGER2 (0.52) | PTGER2 | |
| SCHEMBL5046424 | 0.83 | FNTA (0.44) | LTA4H | |
| SCHEMBL5050405 | 0.83 | PTGER2 (0.48) | PTGER2 | |
| SCHEMBL533204 | 0.78 | PTGER2 (0.81) | PTGER2 | |
| Hydrochloric Acid SCHEMBL10316789 | 0.78 | PTGER2 (0.81) | PTGER2 | |
| SCHEMBL5046626 | 0.78 | PTGER2 (0.46) | PTGER2 | |
| SCHEMBL5050272 | 0.77 | TBXAS1 (0.53) | PTGER2 | |
| SCHEMBL5046359 | 0.77 | PTGER2 (0.50) | PTGER2 | |
| SCHEMBL1471252 | 0.76 | PTGER2 (0.42) | PTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7442702-B2 | Treatment of bone disorders; carboxy derivatives | PFIZER INC. (US) | 2008-10-28 | — | — | US | disclosed |
| EP-1021410-B1 | PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS | PFIZER (US) | 2006-12-27 | — | — | EP | disclosed |
| US-6498172-B1 | (3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL) -PHENOXY)-ACETIC ACID OR SALT; TREATING SUCH AS OSTEOPOROSIS | PFIZER INC. | 2002-12-24 | — | — | US | disclosed |
| EP-1021410-A1 | PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS | PFIZER INC. (US) | 2000-07-26 | — | — | EP | disclosed |
| WO-1999019300-A1 | PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS | PFIZER INC. (US) | 1999-04-22 | — | — | WO | disclosed |